According to a recent article in Nature by a multinational research team, the bacterial metabolite imidazole propionate (ImP) has been identified as a significant and direct driver of atherosclerosis. This molecule, already linked to diabetes and metabolic syndrome, was found to be independently associated with cardiovascular disease, separate from traditional risk factors. Experiments in mice revealed that ImP causes atherosclerosis independent of cholesterol levels by inducing inflammation through a specific signaling pathway involving the I1 imidazoline receptor (I1R). This discovery suggests that blocking the I1R could become a novel, cholesterol-independent therapeutic approach for preventing heart disease, potentially revolutionizing the understanding of metabolic disease and underscoring the profound impact of the gut microbiome on human health.
Microplastics raised plaque 63% in male mice, with no change in cholesterol or weight
Summarises a UC Riverside mouse study: atherosclerosis-prone mice given 10 mg/kg/day microplastics for nine weeks. Males had 63% more plaque in the aortic root and 624% more in the brachiocephalic artery; females had no significant increase. Weight and cholesterol were unchanged, suggesting direct endothelial damage and inflammation. Admin suggests high fiber and Finnish sauna as defenses (not from the study).

